Dr. William Williams, CEO of BriaCell Therapeutics Corp., a company immuno-oncology focused biotechnology company developing a targeted and safe approach to the management of cancer joins eHealth Radio and the Cancer Information and Health News Channels.
Listen to host Eric Michaels & guest Dr. William Williams discuss the following:
Dr. William Williams is a seasoned biopharmaceutical executive with over 35 years of industry and academic expertise, including significant clinical management in multinational pharmaceutical companies. Dr. Williams served as VP of Exploratory Development at Incyte Corporation from 2005 - 2016. There he facilitated entry of over 20 compounds into the clinic, including ruxolitinib (Jakafi), baricitinib, and epacadostat.
Dr. Williams served as Head of Rheumatology Research at the University of Pennsylvania, ran a major research program in receptor biology, including developing bioactive peptides that mimicked granulocyte-macrophage colony-stimulating factor (GM-CSF), a known stimulant of the immune system. He collaborated with David B. Weiner, Ph.D., a well-known leader in immuno-oncology and vaccine research, in the development of DNA vaccines and was able to bring novel DNA vaccines into the clinic for the treatment of cutaneous T cell lymphoma.
Dr. Williams earned his BSc. in Chemistry and Biotechnology from Massachusetts Institute of Technology and Medical Doctorate from Tufts University School of Medicine. Following his residency at the Boston VA Medical Center, Dr. Williams completed fellowship training in Rheumatology and Cellular Immunology at the University of Missouri. He then joined the molecular immunology laboratory of Mark I. Greene, MD, PhD, FRCP, at the University of Pennsylvania, developed novel methods of bioactive peptide design, and collaborated in the study of the activation of the p185/Human epidermal growth factor receptor 2 (HER2) receptor. HER-2 is a protein which is known to promote the growth of cancer cells. Dr. Williams is the named author at over 130 peer reviewed publications, over 15 patents and numerous Investigational New Drugs (INDs) and NDAs.
Website: www.briacell.com
Céline Fournier, PhD, Chief Medical Officer, Echosens Discusses the Clinical Evidence and Future of Liver Screening Technology
JScreen.org: Saving Lives One Swab at a Time
Discover Labs Provides Fast Diagnostic Testing for Patients Nationwide with Ernesto Lizardi
How Digital Technology is Changing the Landscape of Elder Health Care
Buddy: On-demand accident insurance for active people
One Survivor’s Strategies for Saying “No!” to an Eating Disorder
Distributing products that are healthful, convenient, or made for restricted diets and lifestyles
White Coat Influencers: How Primary Care Doctors are Combatting Vaccine Hesitancy Amid Surging Delta Variant
The Pursuit of Cleanliness: Pristine Potty App for a Better Restaurant Experience
The evolving role of digital AI companions in at-home healthcare
Hispanic Heritage Month: Dr. Juan Pablo Frias, M.D. Discusses the Role of FibroScan for Clinical Research Programs
What you Organically Need For Your Mind with Dr. Shara Ally
Going the Extra Mile: Central Ohio Primary Care Physicians Launches Vaccine "Delivery Service" to Provide Shots to Homebound Patients
New Charitable App Promotes “Active Aging”
Natural Healing: It’s Time to Ditch Over-the-Counter Painkillers
The Future of Keeping Your Hands & Home Clean Without Harmful Chemicals
July 28 is World Hepatitis Day: The Role of FibroScan to Cure HCV Among Veterans
Douglas Dieterich, M.D., discusses role of FibroScan in the diagnoses of chronic liver disease
Plus Therapeutics: Gliblastoma, Rhenium NanoLiposome, and Harnessing the Power of Radiation Therapy
Talking With One of America's Top Facial Cosmetic Surgeons!
Join Podbean Ads Marketplace and connect with engaged listeners.
Advertise Today
Create your
podcast in
minutes
It is Free
Good Nurse Bad Nurse
The Relaxback UK Show
On Call With Dr. Anselm Anyoha
The Doctor’s Farmacy with Mark Hyman, M.D.
The Peter Attia Drive